The majority of asthma sufferers present with a type 2 inflammatory response and profile characterised by hyper-production of IL4, IL5, and IL13, increased blood eosinophils and fractional exhaled nitric oxide (FeNO) (Porsbjerg et al., 2023). This evidence concerns the gene IL4 and asthma.